A serological survey of measles vaccine in a rural region of Eskisehir in Turkey

Public Health

Volumn 111, Issue 6, 1997, Pages 373-376

  Metintas S ^a,b   Etiz, S ^a   Akgun Y ^a   Kalyoncu, C ^a   Sariboyaci, M A ^a   Isikli B ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b NONE   (Turkey)

Author keywords

Measles; Rural areas; Seroconversion; Turkey; Vaccine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MATERNAL ANTIBODY; MEASLES ANTIBODY; MEASLES VACCINE;

MEASLES; POLICY IMPLICATION; VACCINATION IMPACT;

ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HUMAN; IMMUNE RESPONSE; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PATIENT INFORMATION; PATIENT SELECTION; RURAL AREA; SCREENING TEST; SEROCONVERSION; SEROLOGY; SEROPREVALENCE; TIME; TURKEY (REPUBLIC);

ESKISEHIR; TURKEY;

EID: 0030704651     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3506(97)00085-1     Document Type: Article

References (20)

1. Last MJ, Wallace BR. Public Health & Preventive Medicine 13th ed. Prentice-Hall: London, 1992; 65-68.
2. Wood DL, Brunell PA. Measles control in the United States. Clin Microbiol Rev 1995; 8: 260-267.
3. Gershon AA. Measles Virus. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 4th ed. Churchill Livingstone: New York, 1995; 1519-1526.
4. UNICEF. The State of the World's Children, 1994.
5. Data of Ministry of Health of Republic of Turkey, 1994.
6. Markowitz EL, Orenstein AW. Measles Vaccines. The Pediatric Clinics of North America, Pediatric Vaccinations. Update 1990.
7. Weigle KA, Murphy D, Brunell P. Enzyme-Linked Immunosorbent Assay for evaluation of immunity to measles virus. J Clin Microbiol 1984; 19: 376-379.
8. Neumann PW, Weber JM, Jessamine AG and O'Shaughnessy MV. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol 1985; 22: 296-298.
9. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay for immunoglobulin G. Immunochemistry 1971; 8: 871-874.
10. Saunders BD, Trapp RG. Basic & Clinical Biostatistics. 2nd ed. Prentice-Hall: London, 1994.
11. Mortimer EA. Preventive Pediatrics and Epidemiology. In: Behrman RE, Kleigman RM, Voughan VC (eds). Nelson Textbook of Pediatrics. 14th ed. W.B. Saunders: Philadelphia, 1994; 147-170.
12. Black FL, Bermann LL, Borgono JM, Capper RA, Carvalho AA, Collis C, Glover D, Hijazi Z, Jacobson DL, Lee YL. Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody. Am J Epidemiol 1986; 124: 442-452.
13. Kanra G, Ceyhan M. Elimination of maternal antibodies against measles. Turk J Pediatr 1991; 33: 217-220.
14. Vaisberg A, Alvarez JO, Hernandez H, Guillen D, Chu P, Colarossi A. Loss of maternally acquired measles antibodies in well-nourished infants and response to measles vaccination, Peru. Am J Public Health 1990; 80: 736-738.
15. Yilmaz N, Artuk Ç. Measles vaccine and the role of maternal measles antibodies in the immunization against measles. Turk Bull Hygiene Exper Biol 1994; 51: 1-6.
16. Kiepiela P, Coovadia HM, Loening WE, Coward P, Abdool Karim SS. Loss of maternal measles antibody in Black South Africa infants in the first year of life - implications for age of vaccination. SAMJ 1991; 79: 145-148.
17. Maldonado YA, Laurence EC, Deltovitz R, Hartzell H, Albrecht P. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 1995; 96: 447-450.
18. Anderson DC, Givner LB, Shearer WT. Active and passive immunization in the prevention of infectious disease. In: Stiehm ER (ed). Immunologic Disorders. 3rd ed. W.B. Saunders: Philadelphia, 1989; 701-703.
19. Rivest P, Bedard L, Arruda H, Trudean G, Remis RS. Risk factors for measles and vaccine efficacy during an epidemic in Montreal. Can J Public Health 1995; 86: 86-90.
20. Bolotovskii VM, Gelikman BG, Auzinia AV, Glinkaia EV. The duration and strength of postvaccinal measles immunity. Zh Mikrobiol Epidemiol Immunobiol 1990; 5: 32-37.